Literature DB >> 31668313

SCLC, Paraneoplastic Syndromes, and the Immune System.

Martin Sebastian1, Sebastian Koschade2, Jan Alexander Stratmann2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31668313     DOI： 10.1016/j.jtho.2019.07.033

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

Review 1.  Molecular profiles of small cell lung cancer subtypes: therapeutic implications.

Authors:  Anna Schwendenwein; Zsolt Megyesfalvi; Nandor Barany; Zsuzsanna Valko; Edina Bugyik; Christian Lang; Bence Ferencz; Sandor Paku; Andras Lantos; Janos Fillinger; Melinda Rezeli; Gyorgy Marko-Varga; Krisztina Bogos; Gabriella Galffy; Ferenc Renyi-Vamos; Mir Alireza Hoda; Walter Klepetko; Konrad Hoetzenecker; Viktoria Laszlo; Balazs Dome
Journal:  Mol Ther Oncolytics       Date:  2021-02-06       Impact factor: 7.200

Review 2.  What Are the Biomarkers for Immunotherapy in SCLC?

Authors:  Vito Longo; Annamaria Catino; Michele Montrone; Pamela Pizzutilo; Tiziana Annese; Francesco Pesola; Ilaria Marech; Sandro Cassiano; Domenico Ribatti; Domenico Galetta
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.